LI
VRTX icon

LMCG Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

LMCG Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,025
Closed -$285K – 483
2014
Q1 		$285K Sell
4,025
-144
-3% -$11.4K 0.01% 441
2013
Q4 		$310K Buy
+4,169
New +$290K 0.01% 438
2013
Q3 		– Sell
-2,561
Closed -$205K – 486
2013
Q2 		$205K Buy
+2,561
New +$189K 0.01% 450

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

LMCG Investments's VRTX Position: Q2 2014 in Review

LMCG Investments sold out of Vertex Pharmaceuticals (VRTX) in Q2 2014, closing a stake of 4,025 shares — an estimated $285K sold.

LMCG Investments first reported a position in VRTX in Q2 2013 and held it in 3 quarters. The position peaked at $310K in Q4 2013. 411 funds tracked by Wall St. Rank hold VRTX as of Q2 2014.

  • LMCG Investments reported no remaining Vertex Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • LMCG Investments sold 4,025 Vertex Pharmaceuticals shares in Q2 2014, an estimated $285K.
  • LMCG Investments first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • LMCG Investments's Vertex Pharmaceuticals position peaked at $310K in Q4 2013.
  • 411 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2014.

Based on LMCG Investments's 13F filing for Q2 2014, filed 11 Aug 2014.